Nick Warwick, Chief Medical Officer at Sandoz, explains what value added medicines (VAMs) are, how they are developed, and which benefits they bring not only to patients.
Value added medicines (VAMs) are an increasingly significant way to provide broader access to innovative treatment options. VAMs are generic medicines that have been enhanced in a variety of ways to better address patients’ needs – and improve patients’ lives.
Dr. Claude Cyr is a critical medical cannabis presciber. In his opinion, medical cannabis should only be used when common therapies are not effective. But what supports his thesis?
Though not without its critics, medical cannabis has been used as a therapy of last resort. Despite growing evidence that medical cannabis can offer further medical benefits, accessing this treatment can be a challenging process for patients – and can raise questions regarding dosing and treatment planning for medical professionals. Researchers and companies, including Sandoz Canada, are working to improve access to this medicine and related information.
For some patients, medical cannabis can be used as an alternative to or along with certain therapies, because it has a broad spectrum of positive effects and a low risk for serious side effects. Three questions with Dr. Blake Pearson, an advocate of medical cannabis because, from his experience, it works.
For years, many patients in Italy had difficulties accessing modern biologic therapies. The lack of clear policies limited the use of biosimilars as cost-effective alternatives. Now, thanks to the persistent efforts of advocates across political and industrial sectors, these state-of-the-art therapies are available for a larger number of patients. A model story about how legislation affects health outcomes.
The Sandoz Healthcare Access Challenge (HACk) goes “beyond the pill” in supporting mobile and digital innovation driven by passionate healthcare entrepreneurs.
